Fondazione IRCCS Istituto Nazionale Dei Tumori ( Site 0431)

Milan 20133

1 studies enrolling now · 1 studies all time

What they study most

Castration-Resistant Prostatic Cancer, Metastasis

Studies at this site

• A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02) — Recruiting now